A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants

Conditions: Systemic Lupus Erythematosus Interventions: Drug: GSK4347859; Drug: Placebo Sponsors: GlaxoSmithKline Not yet recruiting

Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials